ATG7 and gastric cancer: Silencing of CGAP1 inhibited apatinib-induced autophagy by stabilizing miR-3657 to augment its suppression on ATG7 expression; moreover, knockdown of CGAP1 sensitized GC cells to apatinib via autophagy inhibition in vitro and in vivo (112), suggesting that targeting CGAP1 may provide a novel target in the treatment of cisplatin-resistant GC.